| scholarly article | Q13442814 |
| P2093 | author name string | Wei Wang | |
| Benjamin A Garcia | |||
| Akriti Kharbanda | |||
| Xing-Jun Cao | |||
| Eric S Witze | |||
| Ewa Stypulkowski | |||
| Kristin B Runkle | |||
| P2860 | cites work | DHHC9 and GCP16 constitute a human protein fatty acyltransferase with specificity for H- and N-Ras | Q24306928 |
| 2-Bromopalmitate and 2-(2-hydroxy-5-nitro-benzylidene)-benzo[b]thiophen-3-one inhibit DHHC-mediated palmitoylation in vitro | Q24657239 | ||
| Protein Depalmitoylation Is Induced by Wnt5a and Promotes Polarized Cell Behavior | Q27313355 | ||
| Receptor downregulation and multivesicular-body sorting | Q28131720 | ||
| Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing | Q28275103 | ||
| Analysis of deletions of the carboxyl terminus of the epidermal growth factor receptor reveals self-phosphorylation at tyrosine 992 and enhanced in vivo tyrosine phosphorylation of cell substrates | Q28624927 | ||
| Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics | Q29615818 | ||
| Oncogenic mutant forms of EGFR: lessons in signal transduction and targets for cancer therapy | Q33943421 | ||
| Targeting the EGFR signaling pathway in cancer therapy | Q34246558 | ||
| Palmitoylation and depalmitoylation dynamics at a glance | Q34329570 | ||
| ErbB/HER protein-tyrosine kinases: Structures and small molecule inhibitors | Q34424780 | ||
| Glioblastoma-derived epidermal growth factor receptor carboxyl-terminal deletion mutants are transforming and are sensitive to EGFR-directed therapies | Q35623965 | ||
| Palmitoylation controls recycling in lysosomal sorting and trafficking | Q36407241 | ||
| Intracellular activation of EGFR by fatty acid synthase dependent palmitoylation. | Q36544282 | ||
| Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails | Q37002174 | ||
| Endosomes: a legitimate platform for the signaling train | Q37394435 | ||
| DHHC palmitoyl transferases: substrate interactions and (patho)physiology | Q37851213 | ||
| Protein palmitoylation and subcellular trafficking | Q37912382 | ||
| The EGFR family: not so prototypical receptor tyrosine kinases | Q38201344 | ||
| Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3'-kinase and phospholipase C-dependent mechanism | Q73163038 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 385-396 | |
| P577 | publication date | 2016-05-01 | |
| P1433 | published in | Molecular Cell | Q3319468 |
| P1476 | title | Inhibition of DHHC20-Mediated EGFR Palmitoylation Creates a Dependence on EGFR Signaling | |
| P478 | volume | 62 |
| Q92644556 | Activation of JNK and p38 MAPK Mediated by ZDHHC17 Drives Glioblastoma Multiforme Development and Malignant Progression |
| Q90008975 | Blocking EGFR palmitoylation suppresses PI3K signaling and mutant KRAS lung tumorigenesis |
| Q92487810 | CD317 Activates EGFR by Regulating Its Association with Lipid Rafts |
| Q98184275 | Control of protein palmitoylation by regulating substrate recruitment to a zDHHC-protein acyltransferase |
| Q64234556 | Drosophila ZDHHC8 palmitoylates scribble and Ras64B and controls growth and viability |
| Q64077822 | Dysregulated Redox Regulation Contributes to Nuclear EGFR Localization and Pathogenicity in Lung Cancer |
| Q33809433 | FASN Inhibition and Taxane Treatment Combine to Enhance Anti-tumor Efficacy in Diverse Xenograft Tumor Models through Disruption of Tubulin Palmitoylation and Microtubule Organization and FASN Inhibition-Mediated Effects on Oncogenic Signaling and G |
| Q49960728 | Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non-small cell lung cancer |
| Q48257696 | Fatty acyl recognition and transfer by an integral membrane S-acyltransferase. |
| Q38615912 | Identification and dynamics of the human ZDHHC16-ZDHHC6 palmitoylation cascade. |
| Q47815156 | Induced sensitivity to EGFR inhibitors is mediated by palmitoylated cysteine 1025 of EGFR and requires oncogenic Kras |
| Q92886723 | Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours |
| Q64988694 | Kinase-Inactivated EGFR Is Required for the Survival of Wild-Type EGFR-Expressing Cancer Cells Treated with Tyrosine Kinase Inhibitors. |
| Q89390449 | Nicotine induces oral dysplastic keratinocyte migration via fatty acid synthase-dependent epidermal growth factor receptor activation |
| Q92972083 | PD-L1 in the palm of your hand: palmitoylation as a target for immuno-oncology |
| Q38837607 | Palmitoylation of proteins in cancer |
| Q90092966 | Palmitoylation: A Fatty Regulator of Myocardial Electrophysiology |
| Q99565924 | Proteasomal and lysosomal degradation for specific and durable suppression of immunotherapeutic targets |
| Q88964866 | Protein Lipidation in Cell Signaling and Diseases: Function, Regulation, and Therapeutic Opportunities |
| Q47239374 | Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies |
| Q37643588 | Protein S-palmitoylation in cellular differentiation |
| Q47295054 | Protein depalmitoylases. |
| Q94593608 | Recent Findings in the Posttranslational Modifications of PD-L1 |
| Q96110055 | Recurrent EGFR alterations in NTRK3 fusion negative congenital mesoblastic nephroma |
| Q90627490 | Redox regulation of tyrosine kinase signalling: more than meets the eye |
| Q47236781 | The depalmitoylase APT1 directs the asymmetric partitioning of Notch and Wnt signaling during cell division |
| Q47592878 | The palmitoyltransferase ZDHHC20 enhances interferon-induced transmembrane protein 3 (IFITM3) palmitoylation and antiviral activity |
Search more.